These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 29580896)

  • 1. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
    Gomes AS; Ramos H; Soares J; Saraiva L
    Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53.
    Zhao Y; Zhang L; Wu Y; Dai Q; Zhou Y; Li Z; Yang L; Guo Q; Lu N
    Pharmacol Res; 2018 Sep; 135():49-59. PubMed ID: 30031170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect.
    Chen XS; Li LY; Guan YD; Yang JM; Cheng Y
    Acta Pharmacol Sin; 2016 Aug; 37(8):1013-9. PubMed ID: 27374491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
    El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
    Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy.
    Abdel-Wahab AF; Mahmoud W; Al-Harizy RM
    Pharmacol Res; 2019 Dec; 150():104511. PubMed ID: 31678210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect.
    Abukwaik R; Vera-Siguenza E; Tennant D; Spill F
    Bull Math Biol; 2024 Aug; 86(10):124. PubMed ID: 39207627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLMP53-1 Inhibits Tumor Cell Growth through Regulation of Glucose Metabolism and Angiogenesis in a P53-Dependent Manner.
    Ramos H; Calheiros J; Almeida J; Barcherini V; Santos S; Carvalho ATP; Santos MMM; Saraiva L
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
    Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
    Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of targeting cancer metabolism for cancer therapy.
    Farhadi P; Yarani R; Dokaneheifard S; Mansouri K
    Tumour Biol; 2020 Oct; 42(10):1010428320965284. PubMed ID: 33028168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the Warburg effect: historical dogma versus current understanding.
    Vaupel P; Multhoff G
    J Physiol; 2021 Mar; 599(6):1745-1757. PubMed ID: 33347611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose Addiction in Cancer Therapy: Advances and Drawbacks.
    Granja S; Pinheiro C; Reis RM; Martinho O; Baltazar F
    Curr Drug Metab; 2015; 16(3):221-42. PubMed ID: 26504932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor p53 and metabolism.
    Liu J; Zhang C; Hu W; Feng Z
    J Mol Cell Biol; 2019 Apr; 11(4):284-292. PubMed ID: 30500901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor.
    Madan E; Gogna R; Bhatt M; Pati U; Kuppusamy P; Mahdi AA
    Oncotarget; 2011 Dec; 2(12):948-57. PubMed ID: 22248668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lactic acid induces lactate transport and glycolysis/OXPHOS interconversion in glioblastoma.
    Duan K; Liu ZJ; Hu SQ; Huo HY; Xu ZR; Ruan JF; Sun Y; Dai LP; Yan CB; Xiong W; Cui QH; Yu HJ; Yu M; Qin Y
    Biochem Biophys Res Commun; 2018 Sep; 503(2):888-894. PubMed ID: 29928884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer.
    Yeung SJ; Pan J; Lee MH
    Cell Mol Life Sci; 2008 Dec; 65(24):3981-99. PubMed ID: 18766298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic strategies targeting cancer--specific metabolism].
    Makinoshima H; Owada S; Esumi H
    Nihon Rinsho; 2015 Aug; 73(8):1296-301. PubMed ID: 26281681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy.
    Shi Y; Liu S; Ahmad S; Gao Q
    Curr Top Med Chem; 2018; 18(6):454-466. PubMed ID: 29788889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.